Sherbrooke Park Advisers LLC Acadia Pharmaceuticals Inc Transaction History
Sherbrooke Park Advisers LLC
- $436 Billion
- Q3 2024
A detailed history of Sherbrooke Park Advisers LLC transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Sherbrooke Park Advisers LLC holds 18,466 shares of ACAD stock, worth $298,779. This represents 0.07% of its overall portfolio holdings.
Number of Shares
18,466
Previous 22,872
19.26%
Holding current value
$298,779
Previous $372 Million
23.59%
% of portfolio
0.07%
Previous 0.07%
Shares
3 transactions
Others Institutions Holding ACAD
# of Institutions
280Shares Held
156MCall Options Held
901KPut Options Held
314K-
Baker Bros. Advisors LP New York, NY42.9MShares$694 Million7.07% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.8MShares$224 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY13.7MShares$222 Million3.36% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$195 Million0.0% of portfolio
-
State Street Corp Boston, MA5.97MShares$96.7 Million0.0% of portfolio
About ACADIA PHARMACEUTICALS INC
- Ticker ACAD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 161,843,008
- Market Cap $2.62B
- Description
- ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...